Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...

Hims & Hers Health (HIMS) stock falls as the FDA declares that Novo Nordisk's (NVO) weight loss therapies are no longer in ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

“Oh my God, you don’t need it.” “I’ve gained 20 pounds since going into menopause, all in my gut!” “It’s for people with ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

Katie Price has revealed her fears for her son Harvey, 22, who has Prader-Willi syndrome and weighs 28 stone. She has puts ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.